Research
Hormonal
GLP-1 agonists improve blood glucose profiles and reduce cardiovascular risk.
GLP-1 agonists can be recommended for improving glycemic control and reducing cardiovascular risks in diabetic patients.
StrongSupportsmedium confidence
GLP-1 agonists... have advantage of improving the blood glucose profile and reduces the cardiovascular risk also.
Why this rating
Based on published clinical data from various clinical trials.
Source
Clinical Potential of Glucagon-like Peptide-1 Analogs in the Management of Diabesity
Nidhi Sharma et al. · Journal of Diabetology · 2023
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →